edelfosine has been researched along with Leukemia, Myeloid in 5 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Minimal residual disease was measured with flow cytometry using leukemia-associated phenotypes as established at diagnosis." | 2.71 | Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden. ( Feller, N; Jansen-van der Weide, MC; Ossenkoppele, GJ; Schuurhuis, GJ; van der Pol, MA; Westra, GA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feller, N | 1 |
| Jansen-van der Weide, MC | 1 |
| van der Pol, MA | 1 |
| Westra, GA | 1 |
| Ossenkoppele, GJ | 1 |
| Schuurhuis, GJ | 1 |
| Heesbeen, EC | 1 |
| Verdonck, LF | 1 |
| Haagmans, M | 1 |
| van Heugten, HG | 1 |
| Staal, GE | 1 |
| Rijksen, G | 1 |
| Wierenga, PK | 1 |
| Setroikromo, R | 1 |
| Vellenga, E | 1 |
| Kampinga, HH | 1 |
| Bazill, GW | 1 |
| Dexter, TM | 1 |
| Vogler, WR | 1 |
| Whigham, E | 1 |
| Bennett, WD | 1 |
| Olson, AC | 1 |
1 trial available for edelfosine and Leukemia, Myeloid
| Article | Year |
|---|---|
Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Purging; Cryopreservation; Decision Making; Female; Fe | 2005 |
4 other studies available for edelfosine and Leukemia, Myeloid
| Article | Year |
|---|---|
Adsorption and uptake of the alkyllysophospholipid ET-18-OCH3 by HL-60 cells during induction of differentiation by dimethylsulfoxide.
Topics: Adsorption; Biological Transport; Cell Differentiation; Cell Division; Humans; In Vitro Techniques; | 1993 |
Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3).
Topics: Acute Disease; Animals; Bone Marrow Purging; Cell Cycle; Cell Death; Colony-Forming Units Assay; Hem | 2000 |
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; End | 1990 |
Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
Topics: Carbon Radioisotopes; Cell Line; Choline; Humans; Leukemia, Myeloid; Lysophosphatidylcholines; Methi | 1985 |